Losartan cas: 114798-26-4

CAS NO: 114798-26-4
Losartan
Description Review
Description

Losartan is a medication used to treat high blood pressure (hypertension) and reduce the risk of stroke in patients with type 2 diabetes. It belongs to the class of drugs known as angiotensin II receptor blockers (ARBs). Losartan is also known by various synonyms such as Cozaar, Lortaan, and DuP-753. In this article, we will discuss the chemical properties, health benefits, potential effects, product mechanism, safety, side effects, dosing information, and conclusion of Losartan.

Chemical name:

The IUPAC name of Losartan is 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid.

Molecular formula:

The molecular formula of Losartan is C22H23ClN6O.

Formula weight:

The formula weight of Losartan is 422.9 g/mol.

CAS No:

The CAS number of Losartan is 114798-26-4.

Top ten keywords from Google and Synonyms:

  1. Hypertension Medication
  2. Angiotensin II Receptor Blocker
  3. High Blood Pressure
  4. Stroke Prevention
  5. Cozaar
  6. Lortaan
  7. DuP-753
  8. Molecular Formula
  9. Cardiovascular Disease
  10. ARBs

Health benefits of this product:

Losartan is primarily used for the treatment of hypertension and reducing the risk of stroke in patients with type 2 diabetes. By blocking the action of angiotensin II, a hormone that causes vasoconstriction and increases blood pressure, Losartan helps to relax blood vessels, lower blood pressure, and improve blood flow.

Potential effects:

Losartan may have potential effects on the body and mind if not used properly. It can cause low blood pressure, dizziness, and electrolyte imbalances, especially if taken with other blood pressure medications or diuretics. In rare cases, it may cause more severe side effects such as kidney failure or liver damage.

Product mechanism:

Losartan works by selectively blocking the action of the angiotensin II type 1 receptor, which reduces the constriction of blood vessels and lowers blood pressure. The drug also has protective effects on the heart and kidneys by reducing inflammation and oxidative stress.

Safety:

Losartan is generally considered safe when used as directed. However, caution should be exercised when taking the medication with other blood pressure medications or diuretics, as these combinations can increase the risk of low blood pressure and electrolyte imbalances. It is important to disclose all medications and supplements being used to healthcare providers to prevent potential interactions.

Side effects:

The side effects of Losartan include dizziness, fatigue, headache, cough, and gastrointestinal issues such as nausea and diarrhea. In rare cases, it may cause more severe side effects such as kidney failure, liver damage, or allergic reactions. Patients with a history of heart or liver disease should consult their healthcare provider before using Losartan.

Dosing information:

The dosing of Losartan varies depending on the indication and individual patient needs. When used for hypertension, the starting dose is typically 50 mg once daily, with adjustments made based on individual response. When used for stroke prevention in patients with type 2 diabetes, the recommended dose is 50 mg once daily.

Conclusion:

In summary, Losartan is an angiotensin II receptor blocker medication used primarily for the treatment of hypertension and reducing the risk of stroke in patients with type 2 diabetes. The compound works by blocking the action of angiotensin II, a hormone that causes vasoconstriction and increases blood pressure. While it can be effective in managing hypertension and reducing the risk of stroke, caution must be exercised when using the medication due to its potential for interactions and rare but serious side effects. It is important to follow proper dosing and safety protocols when using Losartan to prevent adverse health effects and optimize its therapeutic benefits

Review
Review

ver_code
1/3
X
Send your message to us
please select your country
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei Darussalam
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Caribbean Netherlands
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Cote D'ivoire
  • Cuba
  • Curaçao
  • Cyprus
  • Czech Republic
  • Democratic People's Republic of Korea
  • Democratic Republic of the Congo
  • Denmark
  • Djibouti
  • Dominica
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Fiji
  • Finland
  • France
  • French Guiana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guernsey
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong, China
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Ireland
  • Isle of Man
  • Israel
  • Italy
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Korea
  • Kosovo
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau, China
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Micronesia
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands
  • Netherlands Antilles
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestine
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Barthélemy
  • Saint Helena
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Martin
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Sint Maarten
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and The South Sandwich Islands
  • Spain
  • Sri Lanka
  • State of Libya
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syrian Arab Republic
  • TaiWan, China
  • Tajikistan
  • Tanzania
  • Thailand
  • The Republic of Croatia
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks and Caicos Islands
  • Tuvalu
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • US Virgin Islands
  • Uzbekistan
  • Vanuatu
  • Vatican City State
  • Venezuela
  • Vietnam
  • Wallis and Futuna Islands
  • Western Sahara
  • Western Samoa
  • Yemen
  • Zambia
  • Zimbabwe
ver_code